
Diabetes management has traditionally relied on methods such as finger-prick testing and continuous glucose monitors (CGMs), which often pose challenges due to their invasive nature, cost, and accessibility issues. Max Kopp, a 17-year-old researcher, is pioneering an AI-driven non-invasive glucose monitoring system that promises to address these challenges and revolutionize diabetes care. The Need for a Revolution in Diabetes Care